Molecular-pathological prognostic factors of gastric cancer: a review.
about
A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditionsEmerging role of Hippo pathway in gastric and other gastrointestinal cancersPrognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysisHighly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infectionIdentification of key genes associated with gastric cancer based on DNA microarray data.Association of the GNAS1 T393C polymorphism with tumor stage and survival in gastric cancerGene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer.Variable copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in advanced gastric cancer patients.Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer.Decreased expression of insulin-like growth factor binding protein 6 is associated with gastric adenocarcinoma prognosis.Cytoglobin, the newest member of the globin family, functions as a tumor suppressor geneAnalysis of age and gender associated N-glycoproteome in human whole saliva.COL1A1, PRPF40A, and UCP2 correlate with hypoxia markers in non-small cell lung cancer.Genomic profiling of genes contributing to metastasis in a mouse model of thyroid follicular carcinoma.Diagnostic role of serum interleukin-18 in gastric cancer patients.Reduced expression of transcription factor AP-2α is associated with gastric adenocarcinoma prognosisOlfactomedin-4 regulation by estrogen in the human endometrium requires epidermal growth factor signaling.Clinical potential of DNA methylation in gastric cancer: a meta-analysis.The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer.Pathogenetic mechanisms in gastric cancer.Decreased expression of the mitochondrial metabolic enzyme aconitase (ACO2) is associated with poor prognosis in gastric cancer.Poor prognosis of gastric adenocarcinoma with decreased expression of AHRR.Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2'-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis.ARID3B increases ovarian tumor burden and is associated with a cancer stem cell gene signatureAssociation between EGF +61A/G polymorphism and gastric cancer in Caucasians.Association among polymorphisms in EGFR gene exons, lifestyle and risk of gastric cancer with gender differences in Chinese Han subjects.Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer.Decreased expression of the FOXO3a gene is associated with poor prognosis in primary gastric adenocarcinoma patientsLoss of gastric gland mucin-specific O-glycan is associated with progression of differentiated-type adenocarcinoma of the stomachOlfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1.Decreased expression of the GATA3 gene is associated with poor prognosis in primary gastric adenocarcinomaRole of p16 gene promoter methylation in gastric carcinogenesis: a meta-analysis.Changes in tumor growth and metastatic capacities of J82 human bladder cancer cells suppressed by down-regulation of calreticulin expression.Anti-proliferation effects of Twist gene silencing in gastric cancer SGC7901 cells.Matrix metalloproteinase-7 mRNA and protein expression in gastric carcinoma: a meta-analysis.Frequent amplification of PTP1B is associated with poor survival of gastric cancer patientsPrognostic significance of aberrant gene methylation in gastric cancer.CD44 family proteins in gastric cancer: a meta-analysis and narrative reviewClinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer.
P2860
Q24610591-8E72A257-6482-46CF-9EF6-73F40FD9142CQ26774473-F6D64AB0-4067-4A07-9AFD-942E14276558Q27004677-5B3E4FD9-4841-4765-B34C-A9CE368F20DDQ27851714-95A05733-4E95-4564-9940-B99A757044CCQ28512523-E3EFA725-E9BF-49ED-8F7C-DD9B5AFA942FQ31044596-B6DA2DEE-C9CE-4A10-AD1E-B02C48FF95F8Q33555349-E92129FA-BD93-4FBF-A535-57EA75D63C49Q33557996-B56B2CA1-4A1D-423E-96B4-E41664B75063Q33589639-54A811F4-9719-4EC4-8DF5-53B5A478E6BFQ33659482-91712D22-0CFA-449E-972D-3EF5E8C584B1Q33750793-437F20DA-A084-4F23-90AC-621B80C93FC8Q33769833-70FD3AC8-F756-4506-BBF3-657AF1401E11Q33804518-CAC1C8B7-15D5-471A-8197-A8DA7A1B31F9Q33840757-6096C8EA-C571-45D7-8F0A-B731353E5609Q33895984-DDEEBF58-1DDC-4A60-83BF-4D077FC0AAF5Q34017614-7D99AB6E-0721-462C-9B16-F0B6C8E1682BQ34037832-E9C64FDE-F214-418E-8C34-68B460564376Q34254533-31072DA7-14D1-4579-AF49-BF7DD17DAE11Q34257393-D6A167C0-C171-4E7B-A26D-84D2B5358991Q34274752-27EB426F-E61D-4184-9F70-4EF6873A0F3CQ34326627-EE698EB4-5699-4862-9EF4-E40AA2284272Q34336619-C9031160-6509-4BA4-BC28-5077BB481CD7Q34405285-3B3F15C2-8CA5-4D5E-8415-3D8699320114Q34450695-06AE2289-7227-416F-9E90-B784A6975F98Q34483574-ECF1D611-E9D0-4902-9965-EEE8FC0D221FQ34521412-E52C1EEE-C44B-4058-BFBE-D1E88FC51C03Q34650974-B27F2E9C-323F-4822-A535-D3D66E879A89Q34927102-7B544305-8329-4AB1-A583-49297A6D9A9AQ35032514-D82A3637-78E9-489A-A910-96F3C8DFE369Q35051690-F3A063A1-C641-4FEE-96C4-56B770565A7FQ35083529-3371E08B-7F79-45AC-9FE1-F43A70ECB682Q35087772-A5A03569-08BD-4E4E-9878-EFABF49F689CQ35115056-1B7DA4B3-0C0F-427F-80B7-02C214D4E804Q35168250-8BED8C3E-54A9-48A7-B04D-2E9E3577D713Q35169328-543CCC51-7937-4FA0-A1C9-C16A5F3FBBFCQ35225047-1901D889-C207-4BBC-BF2C-88D083EF0F73Q35565061-719F2E77-6D89-4392-9B36-CD356090D38AQ35609447-842FF6BB-6959-458F-B12B-836D98C67130Q35643626-671A4B4C-8724-4A36-9E03-3E861648FC53Q35677409-939030AE-6B52-46E7-BCB8-263AD52E2D53
P2860
Molecular-pathological prognostic factors of gastric cancer: a review.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Molecular-pathological prognostic factors of gastric cancer: a review.
@ast
Molecular-pathological prognostic factors of gastric cancer: a review.
@en
type
label
Molecular-pathological prognostic factors of gastric cancer: a review.
@ast
Molecular-pathological prognostic factors of gastric cancer: a review.
@en
prefLabel
Molecular-pathological prognostic factors of gastric cancer: a review.
@ast
Molecular-pathological prognostic factors of gastric cancer: a review.
@en
P2093
P1433
P1476
Molecular-pathological prognostic factors of gastric cancer: a review.
@en
P2093
Hirofumi Nakayama
Mariko Shutoh
Naohide Oue
Phyu Phyu Aung
Shunji Matsumura
Wataru Yasui
P2888
P356
10.1007/S10120-005-0320-0
P577
2005-01-01T00:00:00Z